Framingham risk score can predict cognitive decline progression in Alzheimer's disease

Neurobiology of Aging

Volumn 36, Issue 11, 2015, Pages 2940-2945

  Viticchi, Giovanna ^a   Falsetti, Lorenzo ^b   Buratti, Laura ^a   Boria, Cristiano ^a   Luzzi, Simona ^a   Bartolini, Marco ^a   Provinciali, Leandro ^a   Silvestrini, Mauro ^a  

^a UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

^b OSPEDALI RIUNITI   (Italy)

Author keywords

Alzheimer's disease; Framingham cardiovascular risk profile; Vascular risk factors

Indexed keywords

AGED; ALZHEIMER DISEASE; AREA UNDER THE CURVE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CLINICAL DEMENTIA RATING; CONTROLLED STUDY; DETERIORATION; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; FRAMINGHAM CARDIOVASCULAR RISK PROFILE; FRAMINGHAM RISK SCORE; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; COGNITION; GENETICS; PROCEDURES; PSYCHOLOGY; RISK ASSESSMENT; TIME FACTOR; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ATHEROSCLEROSIS; COGNITION; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS;

EID: 84947035843     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2015.07.023     Document Type: Article

References (32)

1. Baldassarre D., Veglia F., Hamsten A., Humphries S.E., Rauramaa R., de Faire U., Smit A.J., Giral P., Kurl S., Mannarino E., Grossi E., Paoletti R., Tremoli E. Progression of carotid intima-media thickness as predictor of vascular events: results from the IMPROVE study. Arterioscler. Thromb. Vasc. Biol. 2013, 33:2273-2279.
2. Cardenas V.A., Reed B., Chao L.L., Chui H., Sanossian N., DeCarli C.C., Mack W., Kramer J., Hodis H.N., Yan M., Buonocore M.H., Carmichael O., Jagust W.J., Weiner M.W. Associations among vascular risk factors, carotid atherosclerosis, and cortical volume and thickness in older adults. Stroke 2012, 43:2865-2870.
3. Coley N., Andrieu S., Jaros M., Weiner M., Cedarbaum J., Vellas B. Suitability of the Clinical Dementia Rating-Sum of Boxes as a single primary endpoint for Alzheimer's disease trials. Alzheimers Dement. 2011, 7:602-610.e2.
4. D'Agostino R.B., Vasan R.S., Pencina M.J., Wolf P.A., Cobain M., Massaro J.M., Kannel W.B. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008, 117:743-753.
5. Debette S., Beiser A., DeCarli C., Au R., Himali J.J., Kelly-Hayes M., Romero J.R., Kase C.S., Wolf P.A., Seshadri S. Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study. Stroke 2010, 41:600-606.
6. de la Torre J.C. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease. J. Alzheimers Dis. 2012, 32:553-567.
7. Frisardi V., Solfrizzi V., Seripa D., Capurso C., Santamato A., Sancarlo D., Vendemiale G., Pilotto A., Panza F. Metabolic-cognitive syndrome: a cross-talk between metabolic syndrome and Alzheimer's disease. Ageing Res. Rev. 2010, 9:399-417.
8. Glodzik L., Rusinek H., Brys M., Tsui W.H., Switalski R., Mosconi L., Mistur R., Pirraglia E., de Santi S., Li Y., Goldowsky A., de Leon M.J. Framingham cardiovascular risk profile correlates with impaired hippocampal and cortical vasoreactivity to hypercapnia. J. Cereb. Blood Flow Metab. 2011, 31:671-679.
9. Gupta A., Preis S.R., Beiser A., Devine S., Hankee L., Seshadri S., Wolf P.A., Au R. Mid-life cardiovascular risk impacts memory function: the Framingham offspring study. Alzheimer Dis. Assoc. Disord. 2014, 28:16-22.
10. Jefferson A.L., Hohman T.J., Liu D., Haj-Hassan S., Gifford K.A., Benson E.M., Skinner J.S., Lu Z., Sparling J., Sumner E.C., Bell S., Ruberg F.L. Adverse vascular risk is related to cognitive decline in older adults. J. Alzheimers Dis. 2015, 44:1361-1373.
11. Kaffashian S., Dugravot A., Elbaz A., Shipley M.J., Sabia S., Kivimäki M., Singh-Manoux A. Predicting cognitive decline: a dementia risk score vs. the Framingham vascular risk scores. Neurology 2013, 80:1300-1306.
12. Luzzi S., Vella L., Bartolini M., Provinciali L., Silvestrini M. Atherosclerosis in the evolution of Alzheimer's disease: can treatment reduce cognitive decline?. J. Alzheimers Dis. 2010, 20:893-901.
13. McKhann G.M., Knopman D.S., Chertkow H., Hyman B.T., Jack C.R., Kawas C.H., Klunk W.E., Koroshetz W.J., Manly J.J., Mayeux R., Mohs R.C., Morris J.C., Rossor M.N., Scheltens P., Carrillo M.C., Thies B., Weintraub S., Phelps C.H. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-269.
14. Nishtala A., Preis S.R., Beiser A., Devine S., Hankee L., Seshadri S., Wolf P.A., Au R. Midlife cardiovascular risk impacts executive function: Framingham offspring study. Alzheimer Dis. Assoc. Disord. 2014, 28:16-22.
15. O'Leary D.H., Polak J.F., Kronmal R.A., Manolio T.A., Burke G.L., Wolfson S.K. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N. Engl. J. Med. 1999, 340:14-22.
16. Park S.H., Kim J.H., Choi K.H., Jang Y.J., Bae S.S., Choi B.T., Shin H.K. Hypercholesterolemia accelerates amyloid β-induced cognitive deficits. Int. J. Mol. Med. 2013, 31:577-582.
17. Paternoster L., Martinez-Gonzalez N.A., Charleton R., Chung M., Lewis S., Sudlow C.L. Genetic effects on carotid intima-media thickness: systematic assessment and meta-analyses of candidate gene polymorphisms studied in more than 5000 subjects. Circ. Cardiovasc. Genet. 2010, 3:15-21.
18. Romero J.R., Beiser A., Seshadri S., Benjamin E.J., Polak J.F., Vasan R.S., Au R., DeCarli C., Wolf P.A. Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study. Stroke 2009, 40:1590-1596.
19. Russ T.C., Hamer M., Stamatakis E., Starr J.M., Batty G.D., Kivimäki M. Does the Framingham cardiovascular disease risk score also have predictive utility for dementia death? An individual participant meta-analysis of 11,887 men and women. Atherosclerosis 2013, 228:256-258.
20. Saunders A.M., Strittmatter W.J., Schmechel D., George-Hyslop P.H., Pericak-Vance M.A., Joo S.H., Rosi B.L., Gusella J.F., Crapper-MacLachlan D.R., Alberts M.J. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993, 43:1467-1472.
21. Silvestrini M., Altamura C., Cerqua R., Pasqualetti P., Viticchi G., Provinciali L., Paulon L., Vernieri F. Ultrasonographic markers of vascular risk in patients with asymptomatic carotid stenosis. J. Cereb. Blood Flow Metab. 2013, 33:619-624.
22. Silvestrini M., Cagnetti C., Pasqualetti P., Albanesi C., Altamura C., Lanciotti C., Bartolini M., Mattei F., Provinciali L., Vernieri F. Carotid wall thickness and stroke risk in patients with asymptomatic internal carotid stenosis. Atherosclerosis 2010, 210:452-457.
23. Silvestrini M., Gobbi B., Pasqualetti P., Bartolini M., Baruffaldi R., Lanciotti C., Cerqua R., Altamura C., Provinciali L., Vernieri F. Carotid atherosclerosis and cognitive decline in patients with Alzheimer's disease. Neurobiol. Aging 2009, 30:1177-1183.
24. Silvestrini M., Viticchi G., Altamura C., Luzzi S., Balucani C., Vernieri F. Cerebrovascular assessment for the risk prediction of Alzheimer's disease. J. Alzheimers Dis. 2012, 32:689-698.
25. Silvestrini M., Viticchi G., Falsetti L., Balucani C., Vernieri F., Cerqua R., Luzzi S., Bartolini M., Provinciali L. The role of carotid atherosclerosis in Alzheimer's disease progression. J. Alzheimers Dis. 2011, 25:719-726.
26. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277:813-817.
27. Touboul P.J., Hennerici M.G., Meairs S., Adams H., Amarenco P., Bornstein N., Csiba L., Desvarieux M., Ebrahim S., Hernandez Hernandez R., Jaff M., Kownator S., Naqvi T., Prati P., Rundek T., Sitzer M., Schminke U., Tardif J.C., Taylor A., Vicaut E., Woo K.S. Mannheim carotid intima-media thickness and plaque consensus (2004-2006-2011) an update on behalf of the advisory board of the 3rd, 4th and 5th watching the risk symposia, at the 13th, 15th and 20th European Stroke Conferences, Mannheim, Germany, 2004, Brussels, Belgium, 2006, and Hamburg, Germany, 2011. Cerebrovasc. Dis. 2012, 34:290-296.
28. Viticchi G., Falsetti L., Vernieri F., Altamura C., Altavilla R., Luzzi S., Bartolini M., Provinciali L., Silvestrini M. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment. J. Alzheimers Dis. 2014, 41:401-410.
29. Viticchi G., Falsetti L., Vernieri F., Altamura C., Bartolini M., Luzzi S., Provinciali L., Silvestrini M. Vascular predictors of cognitive decline in patients with mild cognitive impairment. Neurobiol. Aging 2012, 33:1127.e1-1127.e9.
30. Wahlund L.O., Barkhof F., Fazekas F., Bronge L., Augustin M., Sjögren M., Wallin A., Ader H., Leys D., Pantoni L., Pasquier F., Erkinjuntti T., Scheltens P. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001, 32:1318-1322.
31. Weyer G., Erzigkeit H., Kanowski S., Ihl R., Hadler D. Alzheimer's Disease Assessment Scale: reliability and validity in a multicenter clinical trial. Int. Psychogeriatr. 1997, 9:123-138.
32. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 1998, 97:1837-1847.